|Tat-conjugated PAMAM dendrimers as delivery agents for antisense and siRNA oligonucleotides|
H Kang, R DeLong, MH Fisher, RL Juliano
Pharmaceutical research 22 (12), 2099-2106, 2005
|Functionalized gold nanoparticles for the binding, stabilization, and delivery of therapeutic DNA, RNA, and other biological macromolecules|
RK DeLong, CM Reynolds, Y Malcolm, A Schaeffer, T Severs, ...
Nanotechnology, science and applications 3, 53, 2010
|Characterization of complexes of oligonucleotides with polyamidoamine starburst dendrimers and effects on intracellular delivery|
R Delong, K Stephenson, T Loftus, M Fisher, S Alahari, A Nolting, ...
Journal of pharmaceutical sciences 86 (6), 762-764, 1997
|Inhibition of expression of the multidrug resistance-associated P-glycoprotein of by phosphorothioate and 5'cholesterol-conjugated phosphorothioate antisense oligonucleotides.|
SK Alahari, NM Dean, MH Fisher, R Delong, M Manoharan, KL Tivel, ...
Molecular pharmacology 50 (4), 808-819, 1996
|Novel chemically modified oligonucleotides provide potent inhibition of P-glycoprotein expression|
SK Alahari, R DeLong, MH Fisher, NM Dean, P Viliet, RL Juliano
Journal of Pharmacology and Experimental Therapeutics 286 (1), 419-428, 1998
|Protamine-mediated DNA coating remarkably improves bombardment transformation efficiency in plant cells|
E Sivamani, RK DeLong, R Qu
Plant cell reports 28 (2), 213-221, 2009
|Comparative pharmacokinetics, tissue distribution, and tumor accumulation of phosphorothioate, phosphorodithioate, and methylphosphonate oligonucleotides in nude mice|
RK DeLong, A Nolting, M Fisher, Q Chen, E Wickstrom, M Kligshteyn, ...
Antisense and Nucleic Acid Drug Development 7 (2), 71-77, 1997
|Characterization and performance of nucleic acid nanoparticles combined with protamine and gold|
RK DeLong, U Akhtar, M Sallee, B Parker, S Barber, J Zhang, M Craig, ...
Biomaterials 30 (32), 6451-6459, 2009
|Towards biosensors based on conducting polymer nanowires|
SB Tolani, M Craig, RK DeLong, K Ghosh, AK Wanekaya
Analytical and bioanalytical chemistry 393 (4), 1225-1231, 2009
|Structural characterization and biological evaluation of small interfering RNAs containing cyclohexenyl nucleosides|
K Nauwelaerts, M Fisher, M Froeyen, E Lescrinier, A Van Aerschot, D Xu, ...
Journal of the American Chemical Society 129 (30), 9340-9348, 2007
|Morphology of hydrothermally synthesized ZnO nanoparticles tethered to carbon nanotubes affects electrocatalytic activity for H2O2 detection|
MB Wayu, RT Spidle, T Devkota, AK Deb, RK Delong, KC Ghosh, ...
Electrochimica acta 97, 99-104, 2013
|Triplex formation by a psoralen-conjugated oligodeoxyribonucleotide containing the base analog 8-oxo-adenine|
PS Miller, G Bi, SA Kipp, V Fok, RK DeLong
Nucleic acids research 24 (4), 730-736, 1996
|Novel cationic amphiphiles as delivery agents for antisense oligonucleotides|
RK DeLong, H Yoo, SK Alahari, M Fisher, SM Short, SH Kang, R Kole, ...
Nucleic acids research 27 (16), 3334-3341, 1999
|Probing the interaction at the nano–bio interface using raman spectroscopy: ZnO nanoparticles and adenosine triphosphate biomolecules|
A Bhaumik, AM Shearin, R Delong, A Wanekaya, K Ghosh
The Journal of Physical Chemistry C 118 (32), 18631-18639, 2014
|mPEG-PAMAM-G4 nucleic acid nanocomplexes: enhanced stability, RNase protection, and activity of splice switching oligomer and poly I: C RNA|
J Reyes-Reveles, R Sedaghat-Herati, DR Gilley, AM Schaeffer, KC Ghosh, ...
Biomacromolecules 14 (11), 4108-4115, 2013
|Zinc oxide nanoparticle–poly I: C RNA complexes: Implication as therapeutics against experimental melanoma|
M Ramani, MC Mudge, RT Morris, Y Zhang, SA Warcholek, MN Hurst, ...
Molecular Pharmaceutics 14 (3), 614-625, 2017
|Interaction of MnO and ZnO nanomaterials with biomedically important proteins and cells|
H Gann, G Glaspell, R Garrad, A Wanekaya, K Ghosh, L Cillessen, ...
Journal of Biomedical Nanotechnology 6 (1), 37-42, 2010
|Hepatic distribution and clearance of antisense oligonucleotides in the isolated perfused rat liver|
A Nolting, RK DeLong, MH Fisher, E Wickstrom, GM Pollack, RL Juliano, ...
Pharmaceutical research 14 (4), 516-521, 1997
|pDNA bioparticles: comparative heterogeneity, surface, binding, and activity analyses|
P Medberry, S Dennis, T Van Hecke, RK DeLong
Biochemical and biophysical research communications 319 (2), 426-432, 2004
|Enzyme and cancer cell selectivity of nanoparticles: inhibition of 3-D metastatic phenotype and experimental melanoma by zinc oxide|
RK DeLong, JA Mitchell, RT Morris, J Comer, MN Hurst, K Ghosh, ...
Journal of Biomedical Nanotechnology 13 (2), 221-231, 2017